Use of Novel Therapies in Endometrial Cancer: Update for Managed Care

Program Description

This podcast activity will detail considerations in the treatment and management of patients with endometrial cancer utilizing immune checkpoint inhibitors and emerging immune-based therapies. Faculty experts will highlight current clinical challenges influencing patient access to care and the role of managed care pharmacists in expanding access to new cancer therapies. The role of biomarkers in guiding treatment sequencing as well as strategies to ensure provision of cost-effective treatment for patients with endometrial cancer will also be discussed.

Target audience: Health-system, managed care, oncology, and specialty pharmacist

Activity type: Knowledge

Release date: July 29, 2022

Expiration date: July 29, 2023

Estimated time to complete activity: 0.5 hour
Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

• Review the guideline-recommended role of immune-based therapies in the management of endometrial cancer
• Discuss access to care, cost of care, and cost-effectiveness of immune checkpoint inhibitors in the treatment of endometrial cancer

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hour (0.05 CEU) under the ACPE universal activity number 0290-0000-22-360-H01-P. The activity is available for CE credit through July 29, 2023.

Instructions for Completing the Activity and Receiving CPE Credit

To receive CPE credit, participants must complete the pretest, review the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

Disclosures

Faculty

Laura R. Bobolts, PharmD, BCOP, has no relevant financial relationships with commercial interests to disclose.

Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Kylie Ferrentino; Susan Pordon; Brianna Winters; and Chloe Taccetta have no relevant financial relationships with commercial interests to disclose.

An anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.


Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms